Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gallbladder Neoplasms × Observation × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 4 Oropharyngeal Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Obesity 1 Neurocognitive Disorders 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Helicobacter Infections 1 Gallbladder Neoplasms 1 Cholelithiasis 1 Carcinoma, Renal Cell 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

Gemcitabine 4 Cisplatin 4 pembrolizumab 3 durvalumab 2 Oxaliplatin 2 Capecitabine 2 zanidatamab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tivozanib 1 fludarabine 1 atezolizumab 1 aldesleukin 1 Trastuzumab 1 Tegafur 1 Taxes 1 Specimen Handling 1 S 1 (combination) 1 Platinum 1 Observation 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Ipilimumab 1 Interleukin-2 1 Fluorouracil 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06192719 2026-02-18

EULAT

Centre Paul Strauss

15,000 enrolled

Gastrointestinal

Cholelithiasis, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡